DOI: 10.12890/2021_002681

COVID-19 mRNA Vaccine and Myocarditis

Authors

  • Balraj Singh Department of Hematology-Oncology, Saint Joseph's University Medical Center, Paterson, New Jerse
  • Parminder Kaur Department of Cardiology, Saint Joseph's University Medical Center, Paterson, New Jersey
  • Leon Cedeno Department of Internal Medicine, Saint Joseph's University Medical Center, Paterson, New Jersey
  • Taulant Brahimi Department of Internal Medicine, Saint Joseph's University Medical Center, Paterson, New Jersey
  • Prem Patel Department of Cardiology, Saint Joseph's University Medical Center, Paterson, New Jersey
  • Hartaj Virk Department of Cardiology, Saint Joseph's University Medical Center, Paterson, New Jersey
  • Fayez Shamoon Department of Cardiology, Saint Joseph's University Medical Center, Paterson, New Jersey
  • Manesh Bikkina Department of Cardiology, Saint Joseph's University Medical Center, Paterson, New Jersey

bsriar9@gmail.com

Keywords

COVID-19, severe acute respiratory syndrome coronavirus 2, SARS-CoV-2, myocarditis, COVID-19 vaccine, side effects, adverse events, pericarditis, inflammation of the heart

Abstract

Coronavirus disease 2019 (COVID-19) is believed to have originated in the Hua nan South China Seafood Market in Wuhan and can present with a spectrum of clinical manifestations. We report the case of 24-year-old male patient who developed chest pain after administration of the second dose of the Pfizer-BioNTech mRNA COVID-19 vaccine and who was diagnosed with myocarditis on work-up.

View the entire article

Downloads

References

  1. Detection of viruses in myocardial tissues by polymerase chain reaction: evidence of adenovirus as a common cause of myocarditis in children and adults. J Am Coll Cardiol 2003;42(3):466–472.
  2. Rose NR. Viral myocarditis. Curr Opin Rheumatol 2016;28(4):383–389.
  3. Rezkalla SH, Kloner RA. Viral myocarditis: 1917-2020: from the influenza A to the COVID-19 pandemics. Trends Cardiovasc Med 2021;31(3):163–169.
  4. Halsell JS, Riddle JR, Atwood JE, Gardner P, Shope R, Poland GA, et al. Myopericarditis following smallpox vaccination among vaccinia-naive US military personnel. JAMA 2003;289(24):3283–3289.
  5. Veronese G, Ammirati E, Cipriani M, Frigerio M. Fulminant myocarditis: characteristics, treatment, and outcomes. Anatol J Cardiol 2018;19(4):279–286.
  6. Shimabukuro TT, Cole M, Su JR. Reports of anaphylaxis after receipt of mRNA COVID-19 vaccines in the US—December 14, 2020-January 18, 2021. JAMA 2021;325(11):1101–1102.
  7. Greinacher A, Thiele T, Warkentin TE, Weisser K, Kyrle PA, Eichinger S. Thrombotic thrombocytopenia after ChAdOx1 nCov-19 vaccination. N Engl J Med 2021;384(22):2092–2101.
  8. Centers for Disease Control and Prevention. Myocarditis and pericarditis following mRNA COVID-19 vaccination. 2021. Available from: https://www.cdc.gov/coronavirus/2019-ncov/vaccines/safety/myocarditis.html.
  9. Vogel G, Couzin-Frankel J. Israel reports link between rare cases of heart inflammation and COVID-19 vaccination in young men. Science 2021. Available from: https://www.sciencemag.org/news/2021/06/israel-reports-link-between-rare-cases-heart-inflammation-and-covid-19-vaccination

Published

2021-06-14

Issue

Vol. 8 No. 6 (2021)

Categories

How to Cite

1.
Singh B, Kaur P, Cedeno L, Brahimi T, Patel P, Virk H, et al. COVID-19 mRNA Vaccine and Myocarditis. EJCRIM [Internet]. 2021 Jun. 14 [cited 2026 Nov. 3];8(6). Available from: https://ejcrim.com/index.php/ejcrim/article/view/2681

Most read articles by the same author(s)